Healthequity (NASDAQ:HQY) Shares Down 1.9%

Healthequity Inc (NASDAQ:HQY)’s stock price dropped 1.9% on Thursday . The company traded as low as $62.69 and last traded at $61.97, approximately 22,446 shares traded hands during mid-day trading. A decline of 97% from the average daily volume of 874,132 shares. The stock had previously closed at $63.19.

HQY has been the subject of a number of analyst reports. Raymond James boosted their price target on Healthequity from $85.00 to $90.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Citigroup reaffirmed a “buy” rating on shares of Healthequity in a research report on Friday, June 28th. JPMorgan Chase & Co. set a $80.00 price target on Healthequity and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Zacks Investment Research raised Healthequity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 21st. Finally, Bank of America raised Healthequity from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $75.00 to $90.00 in a research report on Friday, July 19th. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Healthequity presently has a consensus rating of “Buy” and a consensus target price of $87.92.

The company has a debt-to-equity ratio of 0.07, a current ratio of 15.60 and a quick ratio of 15.59. The business has a 50 day moving average price of $72.72 and a 200 day moving average price of $72.39. The firm has a market capitalization of $4.24 billion, a P/E ratio of 64.44, a price-to-earnings-growth ratio of 3.32 and a beta of 1.47.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, June 4th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.11. The business had revenue of $87.05 million for the quarter, compared to analyst estimates of $83.98 million. Healthequity had a return on equity of 14.17% and a net margin of 30.60%. As a group, equities analysts expect that Healthequity Inc will post 1.01 EPS for the current year.

In related news, EVP Delano Ladd sold 6,875 shares of the business’s stock in a transaction dated Monday, July 22nd. The stock was sold at an average price of $80.00, for a total transaction of $550,000.00. Following the transaction, the executive vice president now directly owns 17,833 shares in the company, valued at $1,426,640. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $68.17, for a total value of $272,680.00. Following the transaction, the vice president now owns 64,100 shares in the company, valued at $4,369,697. The disclosure for this sale can be found here. Insiders sold 37,899 shares of company stock worth $2,780,851 over the last quarter. 3.70% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of HQY. Meeder Asset Management Inc. bought a new position in Healthequity during the second quarter valued at about $25,000. BerganKDV Wealth Management LLC bought a new position in Healthequity during the second quarter valued at about $26,000. FTB Advisors Inc. bought a new position in Healthequity during the second quarter valued at about $27,000. Manchester Capital Management LLC bought a new position in Healthequity during the first quarter valued at about $36,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new position in Healthequity during the second quarter valued at about $39,000. Hedge funds and other institutional investors own 97.10% of the company’s stock.

Healthequity Company Profile (NASDAQ:HQY)

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More: What is Cost of Goods Sold (COGS)?

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.